VAXX

Vaxxinity (VAXX)

Vaxxinity Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VAXX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 24	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:VAXX	Vaxxinity Inc
2024/05/10	05 : 09	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:VAXX	Vaxxinity Inc
2024/04/20	07 : 53	GlobeNewswire Inc.	Vaxxinity Issues Shareholder Letter	NASDAQ:VAXX	Vaxxinity Inc
2024/04/20	05 : 27	GlobeNewswire Inc.	Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock	NASDAQ:VAXX	Vaxxinity Inc
2024/03/28	22 : 23	GlobeNewswire Inc.	Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting	NASDAQ:VAXX	Vaxxinity Inc
2024/03/28	05 : 41	GlobeNewswire Inc.	Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates	NASDAQ:VAXX	Vaxxinity Inc
2024/03/08	00 : 32	GlobeNewswire Inc.	Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024	NASDAQ:VAXX	Vaxxinity Inc
2024/02/16	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VAXX	Vaxxinity Inc
2024/02/15	22 : 00	GlobeNewswire Inc.	Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published	NASDAQ:VAXX	Vaxxinity Inc
2024/02/13	22 : 00	GlobeNewswire Inc.	Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	NASDAQ:VAXX	Vaxxinity Inc
2024/02/13	07 : 02	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VAXX	Vaxxinity Inc
2024/02/13	07 : 02	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VAXX	Vaxxinity Inc
2024/01/30	22 : 00	GlobeNewswire Inc.	Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	NASDAQ:VAXX	Vaxxinity Inc
2024/01/18	22 : 00	GlobeNewswire Inc.	Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida	NASDAQ:VAXX	Vaxxinity Inc
2024/01/03	22 : 00	GlobeNewswire Inc.	Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference	NASDAQ:VAXX	Vaxxinity Inc
2023/12/02	00 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VAXX	Vaxxinity Inc
2023/12/01	07 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/12/01	06 : 54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/11/30	07 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/11/30	07 : 10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/11/22	06 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/11/22	06 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/11/14	08 : 50	GlobeNewswire Inc.	Vaxxinity to Present at Upcoming November Medical and Investor Conferences	NASDAQ:VAXX	Vaxxinity Inc
2023/11/08	22 : 30	GlobeNewswire Inc.	Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:VAXX	Vaxxinity Inc
2023/11/08	21 : 53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VAXX	Vaxxinity Inc
2023/11/04	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/10/05	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/10/05	05 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc
2023/09/29	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VAXX	Vaxxinity Inc
2023/09/23	05 : 16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VAXX	Vaxxinity Inc